The FDA to meet on Sept 17, 2014 to discuss testosterone risks

Buy Lab Tests Online

Nelson Vergel

Founder, ExcelMale.com
By Reuters Staff

The U.S. Food and Drug Administration has called an advisory committee meeting on Sept. 17, to discuss the adverse cardiovascular outcomes with the usage of testosterone replacement therapy.

The FDA has called for a joint meeting of the bone, reproductive and urologic drugs advisory committee and the drug safety and risk management advisory committee.


Send the FDA your comments by sending an email to address provided in this link: (http://1.usa.gov/1nPA7Qf)

In June, the FDA said that all testosterone products on the market should include in their labels a general warning about the risk of blood clots in veins.

Can Testosterone Induce Blood Clots and Thrombosis? Interview with Dr Charles Glueck
 
Defy Medical TRT clinic doctor
Buy Lab Tests Online
Defy Medical TRT clinic

Sponsors

enclomiphene
nelson vergel coaching for men
Discounted Labs
TRT in UK Balance my hormones
Testosterone books nelson vergel
Register on ExcelMale.com
Trimix HCG Offer Excelmale
Thumos USA men's mentoring and coaching
Testosterone TRT HRT Doctor Near Me

Online statistics

Members online
6
Guests online
8
Total visitors
14

Latest posts

bodybuilder test discounted labs
Top